Importantly also the acquisition of Global Therapeutics from Blackmores could well be lame duck.
A sizable acquisition for MCP, given MCP's small market cap, and hence will have a significant impact on MCP's future results.
Remember Blackmores effectively mothballed this brand into the too hard basket after trying to increase sales and profits for several years. Along comes MCP to take it off Blackmores hand.
I have my suspicions, why will MCP succeed when Blackmores failed??
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.030(10.3%) |
Mkt cap ! $46.06M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 32.0¢ | 29.0¢ | $37.47K | 118.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31971 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 25330 | 1 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| MCP (ASX) Chart |